Vaxart to Showcase its COVID-19 and Norovirus Oral Pill Vaccine Candidates at World Vaccine Congress Europe 2024

Vaxart sent this email to their subscribers on October 24, 2024.

October 24, 2024 8:00 AM EDT

Vaxart to Showcase its COVID-19 and Norovirus Oral Pill Vaccine Candidates at World Vaccine Congress Europe 2024

View this release →

Or click here to view all releases.

Text-only version of this email

Vaxart, Inc. October 24, 2024 8:00 AM EDT Vaxart to Showcase its COVID-19 and Norovirus Oral Pill Vaccine Candidates at World Vaccine Congress Europe 2024 View this release → Or click here to view all releases.

Show all

The Latest Emails Sent By Vaxart

Stock Quote Notification for Vaxart, Inc.

Stock Quote Notification for Vaxart, Inc.

Stock Quote Notification for Vaxart, Inc.

Stock Quote Notification for Vaxart, Inc.

Vaxart Completes Enrollment of Sentinel Cohort in Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate

Vaxart Completes Enrollment of Sentinel Cohort in Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate

Weekly Summary Alert for Vaxart, Inc.

Weekly Summary Alert for Vaxart, Inc.

Stock Quote Notification for Vaxart, Inc.

Stock Quote Notification for Vaxart, Inc.

Stock Quote Notification for Vaxart, Inc.

Stock Quote Notification for Vaxart, Inc.